635
Participants
Start Date
October 31, 2015
Primary Completion Date
November 30, 2019
Study Completion Date
November 30, 2019
Motivational Interviewing
Cognitive Behavioral Therapy Elements
Care Management
Fluoxetine
Anti-depressant
Fluvoxamine
Anti-depressant
Paroxetine
Anti-depressant
Sertraline
Anti-depressant
Citalopram
Anti-depressant
Venlafaxine
Anti-depressant
Duloxetine
Anti-depressant
Mirtazapine
Anti-depressant
Diphenhydramine
Sleep medication
Trazodone
Sleep medication
Prazosin
Sleep medication
Jacobi Medical Center, The Bronx
University of Rochester, Rochester
Inova Trauma Center, Falls Church
Wake Forest, Winston-Salem
Georgia Regents, Augusta
University of Kentucky, Lexington
Ohio State University, Columbus
University of Cincinnati, Cincinnati
Eskenazi Health, Indianapolis
University of Iowa, Iowa City
The University of Wisconsin Madison, Madison
Regions Hospital, Saint Paul
Louisiana State University, New Orleans
Baylor Health Care System, Dallas
UT Southwestern Medical Center, Dallas
University of Texas Medical Branch at Galveston, Galveston
The University of Utah, Salt Lake City
Honor Health, Scottsdale
Cedars Sinai, Beverly Hills
U.C.L.A. Harbor, Torrance
Santa Clara Valley Medical Center, San Jose
U.C. Davis, Sacramento
Hartford Hospital, Hartford
The University of Vermont, Burlington
National Institutes of Health (NIH)
NIH
National Institute of Mental Health (NIMH)
NIH
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of Washington
OTHER